[
  {
    "ts": null,
    "headline": "Buy 9 Barron's Better Bets (Than T-Bills) From 16 'Safer' July DiviDogs",
    "summary": "My monthly update and commentary on the top dividend stock picks from Barron's Better Bets, July 2025 edition. Read the full report and list of stock picks here on Seeking Alpha.",
    "url": "https://finnhub.io/api/news?id=cc3202f910fad429e65e4e084470664a3bacf73b25553a48119447c6c2f00981",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753898358,
      "headline": "Buy 9 Barron's Better Bets (Than T-Bills) From 16 'Safer' July DiviDogs",
      "id": 136146370,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/78455762/image_78455762.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "My monthly update and commentary on the top dividend stock picks from Barron's Better Bets, July 2025 edition. Read the full report and list of stock picks here on Seeking Alpha.",
      "url": "https://finnhub.io/api/news?id=cc3202f910fad429e65e4e084470664a3bacf73b25553a48119447c6c2f00981"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
    "summary": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=abba78b990730554f53dfc0b2cceeb1b64532c375ad2db321091669da6ea589b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753893600,
      "headline": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
      "id": 136171199,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=abba78b990730554f53dfc0b2cceeb1b64532c375ad2db321091669da6ea589b"
    }
  },
  {
    "ts": null,
    "headline": "Merck Unveils Cost-Cutting Plan: Can it Create Long-Term Value?",
    "summary": "MRK targets $3B in annual savings by 2027 as it cuts jobs and refocuses investment ahead of Keytruda's 2028 patent cliff.",
    "url": "https://finnhub.io/api/news?id=2bc4083672fe6b991f283c1307983699316e8018a6c4de9a1dfd83c88fb4f805",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753879620,
      "headline": "Merck Unveils Cost-Cutting Plan: Can it Create Long-Term Value?",
      "id": 136148954,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "MRK targets $3B in annual savings by 2027 as it cuts jobs and refocuses investment ahead of Keytruda's 2028 patent cliff.",
      "url": "https://finnhub.io/api/news?id=2bc4083672fe6b991f283c1307983699316e8018a6c4de9a1dfd83c88fb4f805"
    }
  },
  {
    "ts": null,
    "headline": "Will Collaboration With Bain Capital Help BMY Advance Its Pipeline?",
    "summary": "Bristol Myers partners with Bain Capital to launch a new autoimmune-focused biotech, out-licensing five key immunology assets.",
    "url": "https://finnhub.io/api/news?id=ca1101480cb2f070faa08eb7064810975d4ead41b9b7139a8246b8a03fde5129",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753878840,
      "headline": "Will Collaboration With Bain Capital Help BMY Advance Its Pipeline?",
      "id": 136129848,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers partners with Bain Capital to launch a new autoimmune-focused biotech, out-licensing five key immunology assets.",
      "url": "https://finnhub.io/api/news?id=ca1101480cb2f070faa08eb7064810975d4ead41b9b7139a8246b8a03fde5129"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb (BMY) Q2 Earnings: What To Expect",
    "summary": "Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be reporting results this Thursday morning. Here’s what you need to know.",
    "url": "https://finnhub.io/api/news?id=0bdd4cc3b68ed1725de307442f4f96b0606d97486c8e4e64e6b48dc41c30afe1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753844842,
      "headline": "Bristol-Myers Squibb (BMY) Q2 Earnings: What To Expect",
      "id": 136130152,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be reporting results this Thursday morning. Here’s what you need to know.",
      "url": "https://finnhub.io/api/news?id=0bdd4cc3b68ed1725de307442f4f96b0606d97486c8e4e64e6b48dc41c30afe1"
    }
  }
]